Navigation Links
Seahorse XF Technology Helps P&G Research the Science of Skin
Date:9/9/2013

BILLERICA, Mass., Sept. 9, 2013 /PRNewswire/ -- As reported in this week's The Scientist Magazine, Seahorse Bioscience XF Extracellular Flux technology is being utilized by Procter & Gamble (P&G) skin care scientists to pioneer applications in cellular bioenergetics, to discover the right ingredient combinations that could positively impact skin's natural bioenergy production and re-energize aged skin cells.

P&G scientists are the first in the beauty industry to employ the Seahorse XF Analyzer, which simultaneously measures mitochondrial respiration and glycolysis in real-time, to research cellular energetics and measure and evaluate the effect of ingredients on cell metabolism.

"The overall aging that we experience, a lot of it is driven by cellular energetics," stated John Oblong, Ph.D., a principal scientist at P&G. Mary Johnson, M.S., also a principal scientist at P&G added, "Seahorse's analyzer has replaced tedious experiments in which researchers had to isolate individual mitochondria or use special electrodes to measure oxygen consumption. The ease of the Seahorse system has ignited an explosion of studies into cellular bioenergetics in the past decade."

The XF Analyzer measures the two major energy pathways of the cell - mitochondrial respiration and glycolysis - in real-time. By profiling the metabolic activity of skin cells, scientists can
now track and measure cellular energy metrics, such as ATP turnover and NADPH levels, to study the impact of free radical stress mimicking UV exposure in young cells compared to old cells.

"It's exciting to see XF technology being used for this type of novel research," stated David Ferrick, Ph.D., Seahorse Bioscience CSO. "Using the XF Analyzer P&G scientists were able to test and determine which compounds promoted respiration and glycolysis, potentially causing the cells to increase their metabolism and possibly making the skin cells healthier and more attractive."

P&G scientists demonstrated that in vitro skin cells under oxidative stress conditions experience a significant decrease in ATP, which leads to reduced cellular activity. Older cells, in particular, showed a heightened sensitivity to oxidative stress response, suggesting that aging and environmental factors negatively impact cells' ability to produce and consume energy.

About Seahorse Bioscience

Providing industry-leading analytical instruments and assay kits for research and drug discovery. Scientists worldwide are advancing their research in understanding the role of mitochondrial function in cancer, neuroscience, immunology, obesity, diabetes, ageing, cardiovascular function, and safety toxicity. Learn more: www.seahorsebio.com

CONTACT: Naomi Goumillout, 978-671-1619, ngoumillout@seahorsebio.com


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
4. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
5. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
8. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
9. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
10. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
11. Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News ... The U.S. ... According to a new report published by New Frontier Data, the ... The accelerating pace of cannabis legalization in the United ... cannabis, are considered to be a major factor that drives growth ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
Breaking Medicine News(10 mins):